VERY key point that WAS NOT discussed in Oral argument is

New Post Public Reply Private Reply Replies (1) Message Board
Hate Liars
699
VERY key point that WAS NOT discussed in Oral argument is underlined below. The basis of what we heard today was from the below Briefs and what the Judges are reviewing. Does this sound familiar? The below excerpt is from SA's written 5/07/2018 response. Care to read more? Use the below link...

The patent claims in this appeal are directed to “out-of-band authentication,” an idea StrikeForce describes as using “two completely separate communication channels to verify a person’s identification.” Br. at 3. This idea is not specific to computers ; it also applies to non-computer communication channels such as paper mail, telephone calls, and human messengers . For example, a parent may ask a relative to pick up a child from preschool. The relative may go to the school on behalf of the parent and convey the parent’s request. To confirm whether the information from the relative is authentic, i.e., whether the parent truly asked the relative to pick up the child, an administrator may call the parent. Thus, the preschool performs out-of-band authentication .

Knobbe Martens 5/07/2018 83-page Response:
https://jumpshare.com/v/qGPBC944xOGw8FIn1o6B

What was Ropes & Gray's written response to that statement?

REPLY ARGUMENT


SecureAuth’s Response ignores the innovative way the Asserted Claims address a particular problem arising from the anonymous nature of modern communications systems—namely, a hacker impersonating an authorized user by using stolen credentials to try to remotely access protected data in a “self-authenticating environment .” Appx32 (2:20-22).

The claimed solutions present a specific technological innovation by using separate access and authentication channels and intercepting and re-routing access requests such that all authentication activity occurs in the isolated authentication channel . Contrary to SecureAuth’s suggestions, this solution is far narrower than the general concept of “out-of-band” authentication.

The patents’ specification—which, for purposes of SecureAuth’s motion, must be taken as true—specifically disparages and distinguishes conventional “in-band” and partially “out-of-band” authentication systems and explains why the claimed architecture overcomes the problems associated with those systems. Specifically, to attack StrikeForce’s completely out-of-band system, a hacker would need to breach two channels simultaneously; it also offers a less costly, tokenless system that could use fixed identifiers, including individualized biometric data. Because the Asserted Claims claim a novel security system for performing completely out-of-band authentication in a specific way that overcomes technological problems in the prior art, these claims are not abstract under Alice step one .

SecureAuth relies on a false analogy between the Asserted Claims and a fictional “preschool security system.” But that analogy is directed to a fundamentally different problem, and a genuinely analogous system would be nonsensical in the real world. SecureAuth’s use of hindsight to concoct a fictional and unworkable pre-computer “analogy” to map onto the claims’ limitations cannot substitute for careful review of the claims.

SecureAuth’s Alice step two arguments also fail. Precedent prohibits defining the claims at a high level of abstraction for step one, but then at step two treating the “idea” more narrowly, as though it already subsumed the invention’s novel features. But that is precisely what the district court did and what SecureAuth invites this Court to do. Whether at step one or step two, the analysis must acknowledge the innovative manner in which the claims arrange otherwise generic components to create a novel system that overcomes the problems in existing systems . Moreover, to the extent necessary, the Court should address claim construction. Relatedly, a court cannot, as SecureAuth urges, hold unpatentable the entirety of the Asserted Claims on the basis of a single claim, claim 53, that, as mischaracterized by SecureAuth, omits critical inventive features found in other asserted claims.

That is precisely what the district court did. The court acknowledged that the limitations StrikeForce identifies would be innovative, but focused exclusively on claim 53, which it read as not having those limitations. On appeal, SecureAuth does not dispute that other claims (e.g., claims 1 of the ’599 and ’701 patents) have those limitations —and StrikeForce maintains they are present in claim 53 as well. To the extent necessary to resolve patentability of other claims, the district court on remand must resolve such claim construction disputes .

Here is the link for more information on R&G's 6/04/2018 41-page Appeal Response to SA :
https://jumpshare.com/v/aQMvkVJwf68GCqreotGS

As well as R&G's 6/11/2018 393-page Support Documentation Appeal Response to SA:
https://jumpshare.com/v/tDD65VB293l4so6Q8f3Y

This is R&G's initial 3/26/2018 174-page Appeal Brief: https://jumpshare.com/v/v16tJSqFzFgZ5JTVkOpH




Zerify Inc (ZRFY) Stock Research Links

ZRFY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 4

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading

Top 5 Most Recently Viewed Articles

SKK Holdings Limited Announces Pricing for Share IPO Offering

Updated Category News Views 65

SKK Holdings Limited Announces Share Pricing for IPO SKK Holdings Limited (“SKK” or the “Company”) (Nasdaq: SKK), a specialized civil engineering service provider in subsurface utility works, has proudly announced the pricing of its initial public offering. The Company will offer 2,500,000 ordinary shares at a public offering price of $4.00 per share, yielding...

Continue Reading
Antelope Enterprise: Financial Performance Insights for 2024

Updated Category News Views 149

Antelope Enterprise Holdings Limited (NASDAQ: AEHL) hit the financial report stage hard back in mid-2024, flaunting numbers that tell quite the tale of both triumphs and tribulations. This company was hustling across two growing fronts: the fast-paced world of livestreaming ecommerce and the burgeoning energy sector down in Texas. Their half-year performance review...

Continue Reading
Olivier Falut Steps Into CFO Role at EUROAPI to Drive Growth

Updated Category News Views 344

Olivier Falut Joins EUROAPI as the New Chief Financial Officer EUROAPI is excited to announce the appointment of Olivier Falut as its new Chief Financial Officer, effective immediately. Olivier will be an integral member of the Executive Committee, succeeding Evelyne Nguyen. Evelyne will ensure continuity and a smooth transition within the company through her support...

Continue Reading
OPEXUS and Casepoint Join Forces for Growth and Innovation

Updated Category News Views 261

OPEXUS and Casepoint Unite for Strategic Growth In a significant development in the technology sector, OPEXUS, a frontrunner in government process management software, and Casepoint, an innovator in data discovery technology, have announced their merger. This significant move comes along with a majority investment from Thoma Bravo, a renowned software investment firm...

Continue Reading
MeiraGTx Holdings: An In-Depth Look at Future Potential

Updated Category News Views 69

MeiraGTx Holdings plc (NASDAQ:MGTX) was a clinical-stage gene therapy firm making waves back in 2024. The company announced a pivotal financial move, securing $50 million through equity financing at $4 per share, largely thanks to a $30 million investment from Sanofi (NYSE:SNY). While this funding boosted MGTX’s war chest, traders were already whispering about the heavy...

Continue Reading